wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37692080-7A103053-3169-4777-830A-DC7C977EE3CD
Q37692080-7A103053-3169-4777-830A-DC7C977EE3CD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37692080-7A103053-3169-4777-830A-DC7C977EE3CD
Phase 1 study of new formulation of patritumab (U3-1287) Process 2, a fully human anti-HER3 monoclonal antibody in combination with erlotinib in Japanese patients with advanced non-small cell lung cancer.
P2860
Q37692080-7A103053-3169-4777-830A-DC7C977EE3CD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37692080-7A103053-3169-4777-830A-DC7C977EE3CD
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5efe886aff84d28c3938b57d85812de745be4c1b
P2860
Phase 1 and dose-finding study of patritumab (U3-1287), a human monoclonal antibody targeting HER3, in Japanese patients with advanced solid tumors.